Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome

Abstract

The antiphospholipid syndrome (APS) is a thrombotic disorder leading to spontaneous abortions, venous thromboses, myocardial infarctions and strokes. Although the syndrome is associated with characteristic autoantibodies, these tests have poor predictive value for thrombosis.

The aim of the study was to determine whether the combined presence of two types of antiphospholipidantibodies can be associated with a high-risk subset of thrombosis-prone patients.

One hundred and thirty-four sera from a lupus clinic were tested for antibodies to β₂-glycoprotein I (β₂GPI), protein S and prothrombin. In a group of 29 patients for whom plasma was available, free (functional) protein S levels were also measured.

Autoantibodies to β₂GPI and protein S are associated with each other. Dual reactivity to β₂GPI and protein S correlates with increased history of thrombotic events (69% of doubly reactive patients) when compared to either type of autoantibodyalone (37% of patients with only anti-β₂GPI and 38% with only anti-protein S, P=0.04 and P=0.01, respectively) or neither reactivity (37%). Among 29 patients tested for free (functional, anticoagulant)protein S levels, the lowest levels were found in patients with antibodies to β₂GPI and/or protein S, and all four patients with a history of thrombosis had below-normal free protein S levels. These associations were not found with antiprothrombin antibodies.

In conclusion dual autoantibodiesto β₂GPI and protein S are associated with increased history of thrombosis in the antiphospholipid syndrome.

Keywords

dual reactivity antiphospholipid syndrome

Get full access to this article

View all access options for this article.

References

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309–1311 .

Sorice M , Arcieri P , Griggi T et al. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency . Thromb Haemost 1996; 75: 555–559 .

Morange PE , Alessi MC , Barthet MC et al. Acquired protein S deficiency, likely due to anti-PS autoantibodies, following a thrombotic event in a patient with a systemic lupus erythematosus . Thromb Haemost 1997; 78: 1416–1417 .

Song KS , Park YS , Kim HK . Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus . Arthritis Rheum 2000; 43: 557–560 .

High KA . Antithrombin III , protein C , and protein S . Naturally occurring anticoagulant proteins . Arch Pathol Lab Med 1988; 112: 28–36 .

Comp PC , Nixon RR , Cooper MR , Esmon CT . Familial protein S deficiency is associated with recurrent thrombosis . J Clin Invest 1984; 74: 2082-2082 .

Ginsberg JS , Demers C , Brill-Edwards P et al. Acquired free protein S deficiency is associated with antiphospholipidantibodies and increased thrombin generation in patients with systemic lupus erythematosus . Am J Med 1995; 98: 379–383 .

Parke AL , Weinstein RE , Bona RD , Maier DB , Walker FJ . The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S . Am J Med 1992; 93: 49–56 .

Tomas JF , Alberca I , Tabernero MD , Cordero M , Del Pino-Montes J , Vicente V . Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus . J Rheumatol 1998; 25: 57–62 .

10.

Hasselaar P , Derksen RH , Blokzijl L et al. Risk factors for thrombosis in lupus patients . Ann Rheum Dis 1989; 48: 933–940 .

11.

Ruiz-Arguelles GJ , Ruiz-Arguelles A , Alarcon-Segovia D et al. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4Bp associated with recent history of venous thromboses, antiphospholipid antibodies and the antiphos-pholipid syndrome . J Rheumatol 1991; 18: 552–558 .

12.

Keeling DM , Campbell SJ , Mackie IJ , Machin SJ , Isenberg DA . Total and free protein S in systemic lupus erythematosus . Thromb Res 1990; 60: 237–240 .

13.

Reverter JC , Tassies D , Font J , Monteagudo J , Escolar G , Ingelmo M , Ordinas A . Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s . Arterioscler Thromb Vasc Biol 1996; 16: 1319–1326 .

14.

Ames PR , Tommasino C , Iannaccone L , Brillante M , Cimino R , Brancaccio V . Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies— a crucial role for acquired free protein S deficiency . Thromb Haemost 1996; 76: 190–194 .

15.

Wattiaux MJ , Herve R , Robert A , Cabane J , Housset B , Imbert JC . Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome . Arthritis Rheum 1994; 37: 1096–1100 .

16.

Amster MS , Conway J , Zeid M , Pincus S . Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipidantibody in a patient with systemic lupus erythematosus . J Am Acad Dermatol 1993; 29: 853–857 .

17.

Moreb J , Kitchens CS . Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases . Am J Med 1989; 87: 207–210 .

18.

Atsumi T , Khamashta MA , Ames PR , Ichikawa K , Koike T , Hughes GR . Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system . Lupus 1997; 6: 358–364 .

19.

Merrill JT , Zhang HW , Shen C et al. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein . Thromb Haemost 1999; 81: 748–757 .

20.

Roubey RA , Eisenberg RA , Harper MF , Winfield JB . ‘Anticardiolipin’ autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding . J Immunol 1995; 154: 954–960 .

21.

Matsuda J , Gohchi K , Gotoh M , Tsukamoto M , Saitoh N . Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies . Ann Hematol 1994; 69: 311–315 .

22.

Lo SC , Salem HH , Howard MA , Oldmeadow MJ , Firkin BG . Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant . Br J Haematol 1990; 76: 380–386 .

23.

Tsakiris DA , Settas L , Makris PE , Marbet GA . Lupus anticoagulantantiphospholipidantibodies and thrombophilia. Relation to protein C–protein S–thrombomodulin . J Rheumatol 1990; 17: 785–789 .

24.

Walker F . Does β2-glycoprotein I inhibit the interaction between protein S and C4b-binding protein? Thromb Haemost 1993; 64: 930-930 (abstract).